A Rare Case of p190 BCR-ABL Chronic Myeloid Leukemia With a Very Good Response to Tyrosine Kinase Inhibitors

The oncoprotein BCR-ABL has distinct fusion proteins generated from the Philadelphia chromosome translocation, depending on the site of the breakpoint on chromosome 22. The p210 is the hallmark of chronic myeloid leukemia. Only 1% - 2% of patients with chronic myeloid leukemia (CML) demonstrate p190...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandhe, Nalinikumari, Vekaria, Mona, Dabak, Vrushali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418323/
https://www.ncbi.nlm.nih.gov/pubmed/34513487
http://dx.doi.org/10.7759/cureus.16914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418323/
https://www.ncbi.nlm.nih.gov/pubmed/34513487
http://dx.doi.org/10.7759/cureus.16914

Ejemplares similares